Abstract

We developed an efficient microwave-assisted three-step synthesis of zolpidem and its fluorinated analogues 1–3. The procedure relays on the utilization of easily accessible and inexpensive starting materials. Our protocol shows superior performance in terms of yield and purity of products, compared to conventional heating systems. Notably, the total time needed for reaction accomplishment is significantly lower comparing to oil bath heating systems. Finally, we have performed a detailed study on the preparation of zolpidem tartrate salt I, and we assessed its particle-sizes using a polarizing microscope. Our goal was to select the appropriate method that generates the acceptable particle-size, since the solid-size directly influences solubility in biological fluids and further bioavailability. We believe that the disclosed procedure will help to produce a lab-scale quantity of zolpidem and its fluorinated derivatives 1–3, as well as zolpidem tartrate salt I, with suitable fine-particle size for further biological experimentation.

Highlights

  • Zolpidem 1 is one of the most widely prescribed hypnotic medications in the United States, with an annual prescription rate of nearly 39 million [1,2]

  • We suspect that the improved performance in toluene mainly depended on the formation of ‘hot spots’, produced by increased microwave absorption at the surface of the insoluble formation of ‘hot spots’, produced by increased microwave absorption at the surface of the insoluble

  • We have disclosed a practical procedure for delivering lab-scale quantities of zolpidem 1 and its fluorinated 2–3 analogues, incorporating microware supported chemistry

Read more

Summary

Introduction

Zolpidem 1 is one of the most widely prescribed hypnotic medications in the United States, with an annual prescription rate of nearly 39 million [1,2]. Zolpidem has featured in several curious case reports that documented the reversal of brain stroke symptoms [6], improvement of motor dysfunction in Parkinson’s disease patients [7] or the effective reduction of chronic pain [8]. All these unique features are attributed to the enhanced synaptic GABA-ergic currents in specific brain regions.

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.